Nanovibronix (NASDAQ:FEED) Announces Earnings Results

Nanovibronix (NASDAQ:FEED) issued its quarterly earnings data on Monday. The company reported ($6.88) EPS for the quarter, FiscalAI reports. Nanovibronix had a negative return on equity of 47.82% and a negative net margin of 712.30%.The firm had revenue of $0.65 million for the quarter.

Nanovibronix Price Performance

Shares of NASDAQ:FEED opened at $1.01 on Tuesday. The stock has a market capitalization of $3.74 million, a price-to-earnings ratio of -0.02 and a beta of 1.59. The stock’s 50-day simple moving average is $1.62. Nanovibronix has a 1 year low of $0.99 and a 1 year high of $17.40.

Analyst Ratings Changes

Several equities research analysts have issued reports on FEED shares. Wall Street Zen raised shares of Nanovibronix from a “strong sell” rating to a “sell” rating in a research note on Tuesday, April 28th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nanovibronix in a report on Friday, April 24th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has an average rating of “Sell”.

About Nanovibronix

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.